المؤلفون: Hsieh CY; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, No.7, Zhongshan S. Rd., Zhongzheng Dist., Taipei City, 100, Taiwan ROC., Tsai TF; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, No.7, Zhongshan S. Rd., Zhongzheng Dist., Taipei City, 100, Taiwan ROC. tftsai@yahoo.com.

المصدر: American journal of clinical dermatology [Am J Clin Dermatol] 2022 Nov; Vol. 23 (6), pp. 869-879. Date of Electronic Publication: 2022 Aug 14.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products*/adverse effects , Cyclosporins*/therapeutic use , Dermatologic Agents*/therapeutic use , Pemphigoid, Bullous*/complications , Pemphigoid, Bullous*/drug therapy , Pemphigoid, Bullous*/epidemiology , Psoriasis*/complications , Psoriasis*/drug therapy, Acitretin/therapeutic use ; Adrenal Cortex Hormones/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Azathioprine/therapeutic use ; Biological Factors/therapeutic use ; Etanercept/therapeutic use ; Humans ; Immunosuppressive Agents/adverse effects ; Methotrexate/therapeutic use ; Niacinamide/therapeutic use ; Rituximab ; Ustekinumab/therapeutic use ; Vitamins/therapeutic use

المؤلفون: Papp K; Probity Medical Research, Inc., Waterloo, Ontario, Canada. kapapp@probitymedical.com., Paul C, Kleyn CE, Huang YH, Tsai TF, Schuster C, El Baou C, Toth A, Riedl E, Mrowietz U

المصدر: Acta dermato-venereologica [Acta Derm Venereol] 2022 Mar 15; Vol. 102, pp. adv00672. Date of Electronic Publication: 2022 Mar 15.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Society for the Publication of Acta Dermato-Venereologica Country of Publication: Sweden NLM ID: 0370310 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-2057 (Electronic) Linking ISSN: 00015555 NLM ISO Abbreviation: Acta Derm Venereol Subsets: MEDLINE

مواضيع طبية MeSH: Dermatologic Agents* , Psoriasis*/chemically induced , Psoriasis*/diagnosis , Psoriasis*/drug therapy, Antibodies, Monoclonal, Humanized ; Humans ; Severity of Illness Index ; Treatment Outcome

المؤلفون: Lin PH; Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan., Tsai TF; Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan, Department of Dermatology, National Taiwan University College of Medicine, Taipei, Taiwan.

المصدر: European journal of dermatology : EJD [Eur J Dermatol] 2021 Apr 01; Vol. 31 (2), pp. 251-252.

نوع المنشور: Letter

بيانات الدورية: Publisher: John Libbey Eurotext Country of Publication: France NLM ID: 9206420 Publication Model: Print Cited Medium: Internet ISSN: 1952-4013 (Electronic) Linking ISSN: 11671122 NLM ISO Abbreviation: Eur J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Dermatologic Agents/*therapeutic use , Psoriasis/*drug therapy, Adult ; Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Retreatment ; Severity of Illness Index ; Treatment Outcome ; Young Adult

المؤلفون: Tsai YC; Department of Dermatology, Far Eastern Memorial Hospital , New Taipei, Taiwan., Tsai TF; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine , Taipei, Taiwan.

المصدر: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2020 May; Vol. 13 (5), pp. 493-503. Date of Electronic Publication: 2020 May 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278296 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-2441 (Electronic) Linking ISSN: 17512433 NLM ISO Abbreviation: Expert Rev Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products/*administration & dosage , Dermatologic Agents/*administration & dosage , Psoriasis/*drug therapy, Biological Products/adverse effects ; Dermatologic Agents/adverse effects ; Drug Substitution ; Humans ; Quality of Life ; Randomized Controlled Trials as Topic

المؤلفون: Huang YW; Department of Education, National Taiwan University Hospital, Taipei, Taiwan., Tsai TF; Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Dermatology, National Taiwan University College of Medicine, Taipei, Taiwan.

المصدر: Expert opinion on drug safety [Expert Opin Drug Saf] 2020 Apr; Vol. 19 (4), pp. 395-402. Date of Electronic Publication: 2020 Mar 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-764X (Electronic) Linking ISSN: 14740338 NLM ISO Abbreviation: Expert Opin Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*adverse effects , Dermatologic Agents/*adverse effects , Psoriasis/*drug therapy, Animals ; Antibodies, Monoclonal/administration & dosage ; Dermatologic Agents/administration & dosage ; Drug Administration Schedule ; Humans ; Interleukin-23 Subunit p19/immunology ; Latent Tuberculosis/complications ; Psoriasis/pathology ; Severity of Illness Index ; Time Factors

المؤلفون: Hsu SH; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Dermatology, National Taiwan University Hospital Yun-Lin Branch, Yunlin, Taiwan., Tsai TF; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

المصدر: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2020 Mar; Vol. 13 (3), pp. 211-232. Date of Electronic Publication: 2020 Apr 07.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278296 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-2441 (Electronic) Linking ISSN: 17512433 NLM ISO Abbreviation: Expert Rev Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products/*administration & dosage , Dermatologic Agents/*administration & dosage , Psoriasis/*drug therapy, Biological Products/adverse effects ; Clinical Trials, Phase III as Topic/methods ; Dermatologic Agents/adverse effects ; Endpoint Determination ; Humans ; Patient Selection ; Psoriasis/pathology ; Research Design ; Severity of Illness Index

المؤلفون: Wu CY; Department of Dermatology, Cathay General Hospital, Taipei, Taiwan., Chiu HY; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Dermatology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan., Tsai TF; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

المصدر: PloS one [PLoS One] 2019 Dec 27; Vol. 14 (12), pp. e0225112. Date of Electronic Publication: 2019 Dec 27 (Print Publication: 2019).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Seroconversion*, Antibodies, Monoclonal, Humanized/*therapeutic use , Dermatologic Agents/*therapeutic use , Latent Tuberculosis/*diagnosis , Psoriasis/*drug therapy, Adult ; Female ; Humans ; Interleukin-17/immunology ; Male ; Middle Aged ; Psoriasis/immunology ; Retrospective Studies ; Tuberculin Test

المؤلفون: Thaçi D; Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany. Electronic address: diamant.thaci@uksh.de., Puig L; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain., Reich K; Dermatologikum Berlin and SCIderm Research Institute, Hamburg, Germany., Tsai TF; Department of Dermatology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan., Tyring S; University of Texas Health Science Center and Center for Clinical Studies, Houston, Texas., Kingo K; Dermatology Clinic, Tartu University Hospital, Department of Dermatology, University of Tartu, Tartu, Estonia., Ziv M; Emek Medical Center, Afula, Israel., Pinter A; Department of Dermatology, University of Frankfurt, Frankfurt am Main, Germany., Vender R; Dermatrials Research Inc, Hamilton, Canada; Venderm Innovations in Psoriasis, Hamilton, Canada., Lacombe A; Novartis Pharma AG, Basel, Switzerland., Xia S; Novartis Beijing Novartis Pharma Co Ltd, Shanghai, China., Bhosekar V; Novartis Healthcare Pvt Ltd, Hyderabad, India., Gilloteau I; Novartis Pharma AG, Basel, Switzerland., Guana A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Blauvelt A; Oregon Medical Research Center, Portland, Oregon.

المصدر: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2019 Dec; Vol. 81 (6), pp. 1405-1409. Date of Electronic Publication: 2019 Aug 06.

نوع المنشور: Comparative Study; Letter; Randomized Controlled Trial

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Patient Reported Outcome Measures*, Antibodies, Monoclonal, Humanized/*therapeutic use , Dermatologic Agents/*therapeutic use , Psoriasis/*drug therapy , Ustekinumab/*therapeutic use, Adult ; Antibodies, Monoclonal, Humanized/adverse effects ; Double-Blind Method ; Humans ; Severity of Illness Index ; Time Factors ; Treatment Outcome

المؤلفون: Lee MG; Department of Dermatology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Huang YH; Department of Dermatology, Chang Gung Memorial Hospital, and College of Medicine, Chang Gung University, Taoyuan, Taiwan., Lee JH; Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee SC; Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea., Kim TG; Department of Dermatology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Aw DC; Division of Medicine, Sengkang General Hospital, Singapore City, Singapore., Bao W; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Dee CMA; Novartis Singapore (Pte) Ltd, Singapore City, Singapore., Guana A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Tsai TF; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

المصدر: The Journal of dermatology [J Dermatol] 2019 Sep; Vol. 46 (9), pp. 752-758. Date of Electronic Publication: 2019 Jul 25.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1346-8138 (Electronic) Linking ISSN: 03852407 NLM ISO Abbreviation: J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*administration & dosage , Dermatologic Agents/*administration & dosage , Psoriasis/*drug therapy , Ustekinumab/*administration & dosage, Adult ; Aged ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized ; Asian People ; Dermatologic Agents/adverse effects ; Double-Blind Method ; Female ; Humans ; Injections, Subcutaneous ; Male ; Middle Aged ; Psoriasis/diagnosis ; Psoriasis/pathology ; Severity of Illness Index ; Skin/drug effects ; Skin/pathology ; Time Factors ; Ustekinumab/adverse effects

المؤلفون: Armstrong A; a Keck School of Medicine , University of Southern California , Los Angeles , CA , USA., Puig L; b Hospital de la Santa Creu i Sant Pau and Universitat Autònoma de Barcelona , Barcelona , Spain., Langley R; c Dalhousie University , Halifax , Nova Scotia., Tsai TF; d National Taiwan University Hospital , Taipei , Taiwan., Song M; e Janssen Research and Development, LLC , Spring House , PA , USA., Wasfi Y; e Janssen Research and Development, LLC , Spring House , PA , USA., Jiang J; e Janssen Research and Development, LLC , Spring House , PA , USA., Li S; e Janssen Research and Development, LLC , Spring House , PA , USA., Han C; e Janssen Research and Development, LLC , Spring House , PA , USA.

المصدر: The Journal of dermatological treatment [J Dermatolog Treat] 2019 Feb; Vol. 30 (1), pp. 27-34. Date of Electronic Publication: 2018 Sep 24.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Validation Study

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE

مواضيع طبية MeSH: Patient Reported Outcome Measures*, Antibodies, Monoclonal/*therapeutic use , Dermatologic Agents/*therapeutic use , Psoriasis/*drug therapy , Psychometrics/*methods, Adult ; Aged ; Antibodies, Monoclonal, Humanized ; Double-Blind Method ; Female ; Humans ; Male ; Medical Records ; Middle Aged ; Quality of Life ; Severity of Illness Index